BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 15218964)

  • 1. Familial B-cell chronic lymphocytic leukemia in a population of patients from Southern Italy.
    Capalbo S; Callea V; Musolino C; Guglielmo P; D'Arena G; Fragasso A; Battista C; Giustolisi R; Brugiatelli M; Liso V
    Int J Hematol; 2004 May; 79(4):354-7. PubMed ID: 15218964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of lymphoproliferative disorders in relatives of patients with B-cell chronic lymphocytic leukemia: relevance of the degree of familial linkage.
    Capalbo S; Trerotoli P; Ciancio A; Battista C; Serio G; Liso V
    Eur J Haematol; 2000 Aug; 65(2):114-7. PubMed ID: 10966171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial risk of lymphoproliferative tumors in families of patients with chronic lymphocytic leukemia: results from the Swedish Family-Cancer Database.
    Goldin LR; Pfeiffer RM; Li X; Hemminki K
    Blood; 2004 Sep; 104(6):1850-4. PubMed ID: 15161669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial occurrence of chronic lymphocytic leukaemia in Norway.
    Tjønnfjord GE; Jønsson V; Ly BE; Johannesen TB
    Tidsskr Nor Laegeforen; 2012 Oct; 132(18):2060-3. PubMed ID: 23038196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence for anticipation in lymphoproliferative tumors in population-based samples.
    Daugherty SE; Pfeiffer RM; Mellemkjaer L; Hemminki K; Goldin LR
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1245-50. PubMed ID: 15894680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticipation in familial chronic lymphocytic leukaemia.
    Wiernik PH; Ashwin M; Hu XP; Paietta E; Brown K
    Br J Haematol; 2001 May; 113(2):407-14. PubMed ID: 11380406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Inheritance in lymphoproliferative disorders].
    Jønsson V; Olsen JH
    Ugeskr Laeger; 2006 Jun; 168(24):2361-6. PubMed ID: 16822421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of familial malignancy in a prospectively screened cohort of patients with lymphoproliferative disorders.
    Brown JR; Neuberg D; Phillips K; Reynolds H; Silverstein J; Clark JC; Ash M; Thompson C; Fisher DC; Jacobsen E; LaCasce AS; Freedman AS
    Br J Haematol; 2008 Nov; 143(3):361-8. PubMed ID: 18729853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal B-cell lymphocytosis in first-degree relatives of patients with sporadic (non-familial) chronic lymphocytic leukaemia.
    Matos DM; Ismael SJ; Scrideli CA; de Oliveira FM; Rego EM; Falcão RP
    Br J Haematol; 2009 Nov; 147(3):339-46. PubMed ID: 19709083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.
    Goldin LR; Björkholm M; Kristinsson SY; Turesson I; Landgren O
    Haematologica; 2009 May; 94(5):647-53. PubMed ID: 19286886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunophenotypic features distinguishing familial chronic lymphocytic leukemia from sporadic chronic lymphocytic leukemia.
    Ahmad E; Steinberg SM; Goldin L; Hess CJ; Caporaso N; Kreitman RJ; Wiestner A; Wilson W; White T; Marti G; Stetler-Stevenson M
    Cytometry B Clin Cytom; 2008 Jul; 74(4):221-6. PubMed ID: 18431797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An overview of genetic predisposition to familial hematological malignancies.
    Hamadou WS; Bouali N; Besbes S; Mani R; Bardakci F; Siddiqui AJ; Badraoui R; Adnan M; Sobol H; Soua Z
    Bull Cancer; 2021; 108(7-8):718-724. PubMed ID: 34052033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial (inherited) leukemia, lymphoma, and myeloma: an overview.
    Segel GB; Lichtman MA
    Blood Cells Mol Dis; 2004; 32(1):246-61. PubMed ID: 14757442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of familial B-CLL in the National Cancer Institute Familial Registry.
    Ishibe N; Sgambati MT; Fontaine L; Goldin LR; Jain N; Weissman N; Marti GE; Caporaso NE
    Leuk Lymphoma; 2001 Jun; 42(1-2):99-108. PubMed ID: 11699227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial aggregation of Hodgkin lymphoma and related tumors.
    Goldin LR; Pfeiffer RM; Gridley G; Gail MH; Li X; Mellemkjaer L; Olsen JH; Hemminki K; Linet MS
    Cancer; 2004 May; 100(9):1902-8. PubMed ID: 15112271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and outcome of familial chronic lymphocytic leukemia.
    Mauro FR; Giammartini E; Gentile M; Sperduti I; Valle V; Pizzuti A; Guarini A; Giannarelli D; Foà R
    Haematologica; 2006 Aug; 91(8):1117-20. PubMed ID: 16885053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating a CLL susceptibility variant in
    Blackburn NB; Marthick JR; Banks A; Charlesworth JC; Marsden KA; Lowenthal RM; Blangero J; Dickinson JL
    Blood; 2017 Jul; 130(1):86-88. PubMed ID: 28490571
    [No Abstract]   [Full Text] [Related]  

  • 18. Familial chronic lymphocytic leukaemia: a survey and review of published studies.
    Yuille MR; Matutes E; Marossy A; Hilditch B; Catovsky D; Houlston RS
    Br J Haematol; 2000 Jun; 109(4):794-9. PubMed ID: 10929032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticipation in families with chronic lymphocytic leukemia and other lymphoproliferative disorders.
    Awan H; Jønsson V; Johannesen TB; Ly B; Tjønnfjord GE
    Transl Oncogenomics; 2010 Mar; 4():1-9. PubMed ID: 21566766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial study of chronic lymphocytic leukemia: aggregation of different malignant processes in families with individuals affected with chronic lymphocytic leukemia.
    Nenova IS; Karnolski IN; Mateva NG; Sotirova KN
    Folia Med (Plovdiv); 2006; 48(1):11-6. PubMed ID: 16918049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.